U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic ...
Lilly says weight-loss pill meets three out of four criteria for FDA commissioner voucher International Mounjaro sales exceed estimates by nearly $1 billion Third-quarter beat reinforces Lilly lead in ...
As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...
Many people turn to the Bible for guidance in times of both triumph and hardship — but some say it can also serve as a guide for physical health. Dr. Josh Axe and Jordan Rubin, co-authors of the book ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Background: Implementing healthy behaviors, particularly a healthy plant-based diet, can play a key role in preventing non-communicable diseases (NCDs). However, behavior change initiation and ...
The city’s Head Start preschool programs will not be required to close this school year, but the change injected fresh uncertainty into an unsettled early childhood system. By Troy Closson New York ...
Hers specializes in women's healthcare, connecting users to virtual consultations for various health concerns, including weight loss. Explore personalized weight loss plans incorporating nutrition ...
There is a growing trend toward healthier lifestyles, with more people recognizing the benefits of balanced nutrition and regular exercise (1). Many attempt to transition to a healthier diet by ...
Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the ...
A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program could run into problems with voluntary participation and concerns about ...